Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. The company is valued at $137.1 billion by market cap. The leading global life sciences and diagnostics innovator is expected to announce its fiscal second-quarter earnings for 2026 before the market opens on Tuesday, Jul. 21.
Ahead of the event, analysts expect DHR to report a profit of $1.83 per share on a diluted basis, up 1.7% from $1.80 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.